The role of papillomaviruses in human cancers

Journal of Environmental Science and Health - Part C Environmental Carcinogenesis and Ecotoxicology Reviews

Volumn 18, Issue 1, 2000, Pages 1-14

  Zur Hausen, Harald ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RESEARCH; HUMAN; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PAPILLOMA VIRUS; REVIEW; VIRUS CARCINOGENESIS; VIRUS GENOME; VIRUS INFECTION;

EID: 0141947147     PISSN: 10590501     EISSN: None     Source Type: Journal    
DOI: 10.1080/10590500009373513     Document Type: Review

References (54)

1. Astori, G. Lavergne, D., Benton, C., Höckmayr, B., Egawa, K., Garbe, C., and de Villiers, E.-M. Human papillomaviruses are commonly found in normal skin of immunocompetent hosts. J. Invest. Dermatol. 1998; 110: 752-755.
2. Berkhout, R.J.M., Tieben, L.M., Smits, H.L., Bouwes-Bavinck, J.N., Vermeer, B.J., and ter Schegget, J. Nested PCR approach for detection and typing of epidermodysplasia verruciformis-associated human papillomavirus types in cutaneous cancers from renal transplant recipients. J. Clin. Microbiol., 1995; 33: 690-695.
3. Bosch, F., Schwarz, E., Boukamp, P., Fusenig, N.E., Bartsch, D., and zur Hausen; H. Supression in vivo of human papillomavirus type 18 E6-E7 gene expression in nontumorigenic HeLa-fibroblast hybrid cells. J. Virol. 1990; 64: 4743-4754
4. Boxman, I.L., Berkhout, R.J., Mulder, L.H., Wolkers, M.C., Bouwes Bavinck, J.N., Vermeer, B.J., and ter Schegget, J. Detection of human papillomavirus DNA in plucked hairs from renal transplant recipients and healthy volunteers. J. Invets. Dermatol. 1997; 108: 712-715.
5. Breitburd, F., Kirnbauer, R., Hubbert, N.L., Nonnenmacher, B., Trin-Dinh desmarquet, C., Orth, G., Schiller, J.T., and Lowy, D.R. Immunization with virus-like particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection. J. Virol. 1995; 69: 3959-3963.
6. Campo, M.S. Infection by bovine papillomavirus and prospects for vaccination. Trends Microbiol. 1995; 3: 92-97
7. Chang, F., Syrjänen, S., Shen, Q., Wang, D., and Syrjänen, K. Human papillomavirus involvement in esophageal precancerous lesions and squamous cell carcinomas as evidenced by microscopy and different DNA techniques. Scand. J. Gastroenterol. 1992; 27: 553-563.
8. Chen, T.M., Peccoraro, G., and Defendi, V. Genetic analysis of in vitro progression of human papillomavirus-transfected human cervical cells. Cancer Res. 1993; 53: 1167-1171.
9. de Villiers, E.-M. Human pathogenic papillomavirus types: an update. Current Top. Microbiol. Immunol. 1994; 186: 1-12.
10. de Villiers, E.-M., Lavergne, D., McLaren, K., and Benton, E.C. Prevailing papillomavirus types in non-melanoma carcinomas of the skin in renal allograft recipients. Int. J. Cancer 1997; 73: 356-361.
11. Dürst, M., Bosch, F.X., Glitz, D., Schneider, A., and zur Hausen, H. Inverse relationship between human papillomavirus (HPV) type 16 early gene expression and cell differentiation in nude mouse epithelial cysts and tumors induced by HPV positive human cell lines. J. Virol. 1991; 65: 796-804.
12. Dürst, M., Glitz, D., Schneider, A., and zur Hausen, H. Human papillomavirus type 16 (HPV 16) gene expression and DNA replication in cervical neoplasia: analysis by in situ hybridization. Virology 1992; 189: 132-140.
13. Forslund, O., Antonsson, A., Nordin, P., Stenquist, B., and Hansson, B.G. A broad range of human papillomavirus types detected with a general PCR method suitable for analysis of cutaneous tumours and normal skin. J. Gen. Virol. 1999; 80: 2437-2443.
14. Funk, J.A., Waga, S., Harry, J.B., Espling, E., Stillman, B., and Galloway, D.A. Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein. Genes Dev. 1997; 11: 2090-2100.
15. Howley, P.M. Papillomavirinae: the viruses and their replication. In Fields Virology (Fields, B.N., Knipe, D.M. and Howley, P.M. eds.) Lippincott-Raven Publ. Philadelphia, 1996; pp.2045-2076.
16. Huibregtse, J.M., Scheffner, M., Beaudenon, S., and Howley, P.M. A family of proteins structurally and functionally related to the E6-AP ubiquitin-protein ligase. Proc. Nat. Acad. Sci. US. 1995; 92: 2563-2567.
17. Hurlin, P.J., Kaur, P., Smith, P.P., Perez-Reyes, N., Blanton, R.A., and McDougall, J.K. Progression of human papillomavirus type 18-immhuman keratinocytes to a malignant phenotype. Proc. Nat. Acad. Sci. USA. 1991; 88: 570-574.
18. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol. 64, Human Papillomaviruses, IARC, Lyon, 1995.
19. Jablonska, S. and Millewski, B. Zur Kenntnis der Epidermodysplasia verruciformis Lewandowsky-Lutz. Dermatologica 1957; 115: 1-22.
20. Jones, D.L., Alani, R.M., and Münger, K. The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1-mediated inhibition of cdk2. Genes Dev. 1997; 11: 2101-2111.
21. Lavergne, D. and de Villiers, E.-M. Papillomavirus in oesophageal papillomas and carcinomas. Int. J. Cancer, 1999; 80: 681-984.
22. Lewandowsky, F. and Lutz, W. Ein Fall einer bisher nicht beschriebenen Hauterkrankung (Epidermodysplasia verruciformis). Arch. Dermatol. Syph. (Berlin) 1922; 141: 193-203.
23. Lutz, W. A propos de l'epidermodysplasie verruciforme. Dermatologica, 1946; 92: 30-43.
24. McDougall, J.K. Immortalization and transformation of human cells by human papillomavirus. Current Top. Microbiol. Immunol. 1994; 186: 101-119.
25. Müller, M., Zhou, J., Rittmüller, C., Burger, A., Gabelsberger, J., Braspenning, J., and Gissmann, L. Chimaeric papillomavirus-like particles. Virology 1997; 234: 93-111.
26. Orth, G., Jablonska, S., Favre, M., Jarzabek-Chorzelska, M., and Rzesa, G. Characterization of two new types of HPV from lesions of epidermodysplasia verruciformis. Proc. Nat. Acad. Sci. U.S. 1978; 75: 1537-1541.
27. Orth, G., Jablonska, S., Jarzabek-Chorzelska, M., Rzesa, G., Obalek, S., Favre, M., and Croissant, O. Characteristics of the lesions and risk of malignant conversion as related to the type of the human papillomavirus involved in epidermodysplasia verruciformis. Cancer Res. 179; 39: 1074-1082..
28. Purdie, K., Pennington, J., Proby, C. et al. The promoter of a novel human papillomavirus HPV 77 associated with skin cancer displays UV-responsiveness which is mediated through a consensus p53 binding sequence. EMBO J., 1999; 18: 5359-536
29. Reznikoff, C.A., Yeager, T.R., Belair, C.D., Salevieva, E., Puthenveettil, J.A., and Stadler, W.M. Elevated p16 at senescence and loss of p16 at immortalization in human papillomavirus 16 E6, but not in E7, transformed human uroepithelial cells. Cancer Res. 1996; 56: 2886-2890.
30. Rigoni-Stern, D. Fatti statistici relativialle malatia cancerose. G. Serv. Prog. Pathol. Therap. 1842; 2: 507-517.
31. Rösl, F., Lengert, M., Albrecht, J., Kleine, K., Zawatzky, R., Schraven, B., and zur Hausen, H. Differential regulation of the JE gene encoding the monocyte chemoattractant protein (MCP-1) in cervical carcinoma cells and derived hybrids. J. Virol. 1994; 68: 2142-2150.
32. Rösl, F., Das, B.C., Lengert, M., Geletneky, K., and zur Hausen, H. Antioxidant-induced changes in AP-1 composition result in a selective suppression of human papillomavirus transcription. J. Virol. 1997; 71: 362-370.
33. Rous, P. and Beard, J.W. Carcinomatous changes in virus-induced papillomas of the skin of rabbits. Proc. Soc. Exp. Biol. & Med. 1934; 32: 578-580.
34. Rous, P. and Friedewald, W.F. The effect of chemical carcinogens on virus-induced papillomas (Shope). J. Exp. Med. 1944; 79: 511-538.
35. Scheffner, M., Werness, B.A., Huibregtse, J.M., Levine, J.M., and Howley, P.M. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 1990; 63: 1129-1136.
36. Schiffman, .M.H. Bauer, H.M., Hoover, R.N. Glass, A.G. Cadell, D.M. Rush, B.B., Scott, D.R., Sherman, M.e., Kurman, R.J., and Wacholder, S. Epidemiological evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J. Natl. Cancer Inst. 1993; 85: 958-964
37. Shamanin, V., zur Hausen, H., Lavergne, D., Proby, C., Leigh, I.M., Neumann, C., Hamm, H., Goos, M., Haustein, U.-F., Jung, E.G., Plewig, G., Wolff, H., and de Villiers, E.-M. 1996. Human papillomavirus infections in non-melanoma skin cancers from renal transplant recipients and nonimmunosuppressed patients. J. Natl. Cancer Inst., 88, 802-811.
38. Shamanin, V., zur Hausen, H., Lavergne, D., Proby, C., Leigh, I.M., Neumann, C., Hamm, H., Goos, M., Haustein, U.-F., Jung, E.G., Plewig, G., Wolff, H., and de Villiers, E.-M.. Human papillomavirus infections in non-melanoma skin cancers from renal transplant recipients and nonimmunosuppressed patients. J. Natl. Cancer Inst. 1996: 88: 802-811.
39. Soto, U., Das, B.C., Lengert, M., Finzer, P., zur Hausen, H., and Rösl, F. Conversion of HPV 18 positive non-tumorigenic HeLa-fibroblast hybrids to invasive growth involves loss of TNF-α mediated repression of viral transcription and modification of the AP-1 transcription complex. Oncogene 1999; 18: 3187-3198.
40. Stoler, M.H., Rhodes, C.R., Whitbeck, A., Wolinske, S.M., Chow, L.T., and Broker, T.R.. Human papillomavirus type 16 and 18 gene expression in cervical neoplasias. Hum. Pathol. 1992; 23: 117-128.
41. Suzich, J.A., Ghim, S.J., Palmer-Hill, F.J., White, W.I., Tamura, J.K., Bell, J.A., Newsome, J.A., Jenson, A.B., and Schlegel, R. Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas. Proc. Nat. Acad. Sci. US. 1995; 92: 11553-11557.
42. Tommasino, M. (Editor). Papillomaviruses in human cancer: the role of E6 and E7 oncoproteins. Springer-Verlag New York, Berlin, Heidelberg, 1997.
43. von Knebel Doeberitz, M., Rittmüller, C., Glitz, D., zur Hausen, H. and Dürst, M. Inhibition of tumorigenicity by cervical cancer cells in nude mice by HPV 18 E6-E7 antisense RNA. Int. J. Cancer 1992; 51: 831-834.
44. von Knebel Doeberitz, M., Rittmüller, C., Aengeneyndt, F., Jansen-Dürr, P., and Spitkovsky, D. Reversible repression of papillomavirus oncogene expression in cervical carcinoma cells: consequences for the phenotype and E6-p53 and E7-pRB interactions. J. Virol. 1994; 68: 2811-2821.
45. Werness, B.A., Levine, A.J., and Howley, P.M. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 1990; 248: 76-79.
46. White, A.E., Livanos, E.M., and Tlsty, T.D. Differential disruption of genomic integrity and cell cycle regulation in normal human fibroblasts by the HPV oncoproteins. Genes and Development 1994; 8: 666-677.
47. Zerfass-Thome, K., Zwerschke, W., Mannhardt, B., Tindle, R., Botz, J.W., and Jansen-Dürr, P. Inactivation of the cdk inhibitor p27KIP1 by the human papillomavirus type 16 E7 oncoprotein. Oncogene 1996; 13: 2323-2330.
48. zur Hausen, H. Cell-virus gene balance hypothesis of carcinogenesis. Behring Inst. Mitt. 1977; 61: 23-30.
49. zur Hausen, H. Genital papillomavirus infections. In: Viruses and Cancer, P.W.J. Rigby and N.M. Wilkie (eds.), Cambridge University Press, 1986; pp.83-90.
50. zur Hausen, H. Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 1991; 184: 9-13.
51. zur Hausen, H. Disrupted dichotomous intracellular control of human papillomavirus infection in cancer of the cervix. Lancet 1994; 343: 955-957
52. zur Hausen, H. Papillomavirus infections - a major cause of human cancers. Biochem. Biophys. Acta, Rev. on Cancer, 1996; 1288: F55-F78.
53. zur Hausen, H. Papillomaviruses in human cancers. Proc. Assoc. Am. Phys. 1999; 111:581-587.
54. zur Hausen, H. Papillomaviruses causing cancer: the evasion from host cell control marks early events in carcinogenesis, J. Nat. Cancer Inst., 2000, in press.